04

July 4, 2019

Curing autoimmune diabetes  (TIDM) with interleukin 1 receptor antagonists:Anakinra-based therapy for autoimmune diabetes: Anakinra (brand name: Kineret and others),  an interleukin 1 receptor antagonist used in the treatment of rheumatoid arthritis, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 4/July/2019, 11.03 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and […]
July 4, 2019

Rotavirus Vaccine-based curative therapy for autoimmune (Type I) diabetes (TIDM):  Rotavirus vaccine promotes the expression of PD-L1, attenuates the expression of tumor suppressor TXNIP, augments Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 4/July/2019, 8.17 pm

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical […]
July 4, 2019

Probiotic-based therapy for aging-associated diseases and Lifespan extension: Probiotic Lactobacillus Fermentum DR9 ( (LF-DR9)  inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 4/July/2019, 8.17 am

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]